Showing results (41-50 of 172) with videos related to
Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694Ahmad A Tarhini, Joseph Stuckert, Sandra Lee, et al.Nature Clinical Practice. Oncology|December 19, 2008
Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?John M Kirkwood, Hussein A Tawbi, Ahmad A Tarhini, et al.Plos One|January 23, 2016
Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma PatientsKathan Mehta, Leonard Appleman, Hong Wang, et al.Oncoimmunology|October 25, 2019
The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patientsArjun Khunger, Julie A Rytlewski, Paul Fields, et al.Cancers|March 29, 2023
Leptomeningeal Disease (LMD) in Patients with Melanoma MetastasesMariam Lotfy Khaled, Ahmad A Tarhini, Peter A Forsyth, et al.Cancer|August 23, 2008
A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanomaAhmad A Tarhini, John M Kirkwood, William E Gooding, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapyAhmad A Tarhini, John M Kirkwood, William E Gooding, et al.CA: a Cancer Journal for Clinicians|May 12, 2012
Immunotherapy of cancer in 2012John M Kirkwood, Lisa H Butterfield, Ahmad A Tarhini, et al.International Journal of Molecular Sciences|May 13, 2023
A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with IpilimumabIyad Kobeissi, Islam Eljilany, Tala Achkar, et al.Immunotherapy|June 24, 2020
Long-term control of leptomeningeal disease after radiation therapy and nivolumab in a metastatic melanoma patientRichard C Wu, William Newman, Liron Patanowitz, et al.Pageof 18